Pharmafile Logo
Pharmafocus logo
Advanced Search

Tracleer

Showing 5 posts of 5 posts found.

Actelion image

Jobs under threat in Actelion cost saving

July 12, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Actelion, R&D, Tracleer, cuts

Swiss speciality pharmaceutical company Actelion has unveiled a new cost saving plan which could include the loss of 260 jobs …

News

Actelion boosted by trial success

April 30, 2012
Research and Development, Sales and Marketing Actelion, Tracleer, almorexant, macitentan

Actelion’s pulmonary arterial hypertension drug macitentan has met its primary endpoint in a Phase III trial.  The news comes after …

News

Actelion defends itself against investor aggression

March 9, 2011
Sales and Marketing Actelion, Tracleer, almorexant

Swiss biotech firm Actelion is mounting a defence of its management board and strategy following an offensive by a shareholder …

News
Tracleer1

Tracleer continues to fuel Actelion growth

February 19, 2010
Sales and Marketing Actelion, Tracleer

Actelion has posted a 20% increase in revenue on the strength of its pulmonary hypertension treatment Tracleer. The drug saw …

News

Tracleer expansion fuels Actelion growth

July 22, 2009
Sales and Marketing Actelion, Tracleer

Sales of pulmonary arterial hypertension treatment Tracleer are continuing to grow worldwide, helping to boost the fortunes of Actelion. The …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025